Key points from article :
Doctors took the blood of 200 adults, children newly diagnosed with cancer before they had started treatment.
Antibody can be attached to a protein CD33, on the surface of MDSCs, for destroying the protective layer.
By using drug gentuzumab ozogamicin, researchers were able to kill the MDSCs in the samples.
Research has done by the University of Birmingham.
The study was published in EBioMedicine journal.
